1029 genomes of self-declared healthy individuals from India reveal prevalent and clinically relevant cardiac ion channelopathy variants.
ACMG/AMP
Cardiac channelopathies
Genome sequencing
IndiGen
Indian population
Population screening
Prevalence
Journal
Human genomics
ISSN: 1479-7364
Titre abrégé: Hum Genomics
Pays: England
ID NLM: 101202210
Informations de publication
Date de publication:
05 08 2022
05 08 2022
Historique:
received:
25
02
2022
accepted:
11
07
2022
entrez:
5
8
2022
pubmed:
6
8
2022
medline:
10
8
2022
Statut:
epublish
Résumé
The prevalence and genetic spectrum of cardiac channelopathies exhibit population-specific differences. We aimed to understand the spectrum of cardiac channelopathy-associated variations in India, which is characterised by a genetically diverse population and is largely understudied in the context of these disorders. We utilised the IndiGenomes dataset comprising 1029 whole genomes from self-declared healthy individuals as a template to filter variants in 36 genes known to cause cardiac channelopathies. Our analysis revealed 186,782 variants, of which we filtered 470 variants that were identified as possibly pathogenic (440 nonsynonymous, 30 high-confidence predicted loss of function ). About 26% (124 out of 470) of these variants were unique to the Indian population as they were not reported in the global population datasets and published literature. Classification of 470 variants by ACMG/AMP guidelines unveiled 13 pathogenic/likely pathogenic (P/LP) variants mapping to 19 out of the 1029 individuals. Further query of 53 probands in an independent cohort of cardiac channelopathy, using exome sequencing, revealed the presence of 3 out of the 13 P/LP variants. The identification of p.G179Sfs*62, p.R823W and c.420 + 2 T > C variants in KCNQ1, KCNH2 and CASQ2 genes, respectively, validate the significance of the P/LP variants in the context of clinical applicability as well as for large-scale population analysis. A compendium of ACMG/AMP classified cardiac channelopathy variants in 1029 self-declared healthy Indian population was created. A conservative genotypic prevalence was estimated to be 0.9-1.8% which poses a huge public health burden for a country with large population size like India. In the majority of cases, these disorders are manageable and the risk of sudden cardiac death can be alleviated by appropriate lifestyle modifications as well as treatment regimens/clinical interventions. Clinical utility of the obtained variants was demonstrated using a cardiac channelopathy patient cohort. Our study emphasises the need for large-scale population screening to identify at-risk individuals and take preventive measures. However, we suggest cautious clinical interpretation to be exercised by taking other cardiac channelopathy risk factors into account.
Sections du résumé
BACKGROUND
The prevalence and genetic spectrum of cardiac channelopathies exhibit population-specific differences. We aimed to understand the spectrum of cardiac channelopathy-associated variations in India, which is characterised by a genetically diverse population and is largely understudied in the context of these disorders.
RESULTS
We utilised the IndiGenomes dataset comprising 1029 whole genomes from self-declared healthy individuals as a template to filter variants in 36 genes known to cause cardiac channelopathies. Our analysis revealed 186,782 variants, of which we filtered 470 variants that were identified as possibly pathogenic (440 nonsynonymous, 30 high-confidence predicted loss of function ). About 26% (124 out of 470) of these variants were unique to the Indian population as they were not reported in the global population datasets and published literature. Classification of 470 variants by ACMG/AMP guidelines unveiled 13 pathogenic/likely pathogenic (P/LP) variants mapping to 19 out of the 1029 individuals. Further query of 53 probands in an independent cohort of cardiac channelopathy, using exome sequencing, revealed the presence of 3 out of the 13 P/LP variants. The identification of p.G179Sfs*62, p.R823W and c.420 + 2 T > C variants in KCNQ1, KCNH2 and CASQ2 genes, respectively, validate the significance of the P/LP variants in the context of clinical applicability as well as for large-scale population analysis.
CONCLUSION
A compendium of ACMG/AMP classified cardiac channelopathy variants in 1029 self-declared healthy Indian population was created. A conservative genotypic prevalence was estimated to be 0.9-1.8% which poses a huge public health burden for a country with large population size like India. In the majority of cases, these disorders are manageable and the risk of sudden cardiac death can be alleviated by appropriate lifestyle modifications as well as treatment regimens/clinical interventions. Clinical utility of the obtained variants was demonstrated using a cardiac channelopathy patient cohort. Our study emphasises the need for large-scale population screening to identify at-risk individuals and take preventive measures. However, we suggest cautious clinical interpretation to be exercised by taking other cardiac channelopathy risk factors into account.
Identifiants
pubmed: 35932045
doi: 10.1186/s40246-022-00402-2
pii: 10.1186/s40246-022-00402-2
pmc: PMC9354277
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
30Informations de copyright
© 2022. The Author(s).
Références
Nat Genet. 2016 Sep;48(9):1071-6
pubmed: 27428751
PLoS One. 2014 Jun 26;9(6):e100560
pubmed: 24967631
Nucleic Acids Res. 2007 Jan;35(Database issue):D61-5
pubmed: 17130148
Glob Cardiol Sci Pract. 2015 Oct 13;2015(3):39
pubmed: 26566530
Heart Rhythm. 2011 Mar;8(3):412-9
pubmed: 21070882
Nucleic Acids Res. 2021 Jan 8;49(D1):D1225-D1232
pubmed: 33095885
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Eur J Hum Genet. 2012 Aug;20(8):905-8
pubmed: 22378279
BMC Med Genet. 2011 May 20;12:71
pubmed: 21599885
Pharmacogenomics. 2014 Jul;15(10):1337-54
pubmed: 25155935
Hum Genome Var. 2016 Jun 30;3:16016
pubmed: 27408750
Nature. 2002 Jan 10;415(6868):213-8
pubmed: 11805845
Front Cardiovasc Med. 2021 Apr 21;8:652027
pubmed: 33969014
Ann Clin Lab Sci. 2017 Aug;47(4):481-490
pubmed: 28801377
Cell. 1995 Mar 10;80(5):795-803
pubmed: 7889573
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
J Cardiovasc Electrophysiol. 2012 Oct;23(10):1092-8
pubmed: 22882672
Nat Genet. 2017 Sep;49(9):1403-1407
pubmed: 28714977
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Circulation. 2019 Aug 13;140(7):595-610
pubmed: 31403841
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Cell. 1995 Mar 10;80(5):805-11
pubmed: 7889574
Circ Res. 2013 Mar 1;112(5):826-30
pubmed: 23303164
Nucleic Acids Res. 2017 Jan 4;45(D1):D840-D845
pubmed: 27899611
Circulation. 2006 Jan 24;113(3):356-64
pubmed: 16415378
Nature. 2019 Dec;576(7785):106-111
pubmed: 31802016
Database (Oxford). 2010 Sep 15;2010:baq022
pubmed: 20843867
Nucleic Acids Res. 2020 Jan 8;48(D1):D835-D844
pubmed: 31777943
Circulation. 2014 Jul 8;130(2):147-60
pubmed: 24895455
Int J Androl. 2009 Dec;32(6):647-55
pubmed: 18798765
Circulation. 2020 Feb 11;141(6):418-428
pubmed: 31983240
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Heart Rhythm. 2020 Mar;17(3):492-500
pubmed: 31557540
Genet Med. 2016 Nov;18(11):1165
pubmed: 26986878
Circulation. 2006 Jan 24;113(3):365-73
pubmed: 16432067
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Heart Rhythm. 2012 Jan;9(1):145-50
pubmed: 21816129
Heart Rhythm. 2016 Jan;13(1):289-98
pubmed: 26282245
Nat Genet. 1996 Jan;12(1):17-23
pubmed: 8528244
Circulation. 2022 Mar 22;145(12):877-891
pubmed: 34930020
Hum Mutat. 2016 Mar;37(3):235-41
pubmed: 26555599
Hum Genomics. 2019 Sep 25;14(1):52
pubmed: 31554517